Garner Health Raises $118 Million Series D Led by Kleiner Perkins

February 11, 2026
Garner Health has raised $118 million in Series D funding led by Kleiner Perkins, bringing its valuation to $1.35 billion. The company plans to expand its AI-driven provider-ranking engine and incentive platform serving over 2.5 million members.

New York-based Garner Health has raised $118 million in Series D funding led by Kleiner Perkins, announced in a press release. The round included participation from Redpoint, Maverick, Kaiser Permanente Ventures, Mercy, Plus Capital, and other existing investors, valuing the company at $1.35 billion.

The funding brings Garner’s total capital raised to about $200 million. The company said it will use the new funds to expand its AI-powered provider-ranking engine and incentive platform, which helps lower healthcare costs for over 2.5 million members. The platform identifies high-performing doctors using one of the nation’s largest medical datasets, covering more than 320 million patient records.

Garner reported revenue growth of over 130% year-over-year as employers seek alternatives to traditional provider search tools. The company’s system incentivizes patients to choose top-rated providers by reducing or covering out-of-pocket costs, resulting in average first-year employer savings of 12%.

Garner currently works with more than 700 clients, including large employers, health plans, and healthcare providers across the United States.

We hope you enjoyed this article.

Subscribe to AI Funding Brief

Market report

2025 Generative AI in Professional Services Report

Thomson Reuters

This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.

Read more